These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15475838)

  • 1. A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling.
    Ohashi N; Mitamura H; Tanimoto K; Fukuda Y; Kinebuchi O; Kurita Y; Shiroshita-Takeshita A; Miyoshi S; Hara M; Takatsuki S; Ogawa S
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):386-92. PubMed ID: 15475838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inefficacy of a highly selective T-type calcium channel blocker in preventing atrial fibrillation related remodeling.
    Kato T; Iwasaki YK; Duker G; Fjellstrom O; Giordanetto F; Sundqvist M; Wallin A; Wang QD; Nattel S
    J Cardiovasc Electrophysiol; 2014 May; 25(5):531-536. PubMed ID: 24330029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs.
    Fareh S; Bénardeau A; Thibault B; Nattel S
    Circulation; 1999 Nov; 100(21):2191-7. PubMed ID: 10571979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial electrical remodeling by rapid pacing in the isolated rabbit heart: effects of Ca++ and K+ channel blockade.
    Wood MA; Caponi D; Sykes AM; Wenger EJ
    J Interv Card Electrophysiol; 1998 Mar; 2(1):15-23. PubMed ID: 9869992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily oral verapamil before but not after rapid atrial excitation prevents electrical remodeling.
    Kurita Y; Mitamura H; Shiroshita-Takeshita A; Yamane A; Ieda M; Kinebuchi O; Sato T; Miyoshi S; Hara M; Takatsuki S; Ogawa S
    Cardiovasc Res; 2002 May; 54(2):447-55. PubMed ID: 12062349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs.
    Fareh S; Bénardeau A; Nattel S
    Cardiovasc Res; 2001 Mar; 49(4):762-70. PubMed ID: 11230975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation.
    Ohashi N; Mitamura H; Ogawa S
    Drugs; 2009; 69(1):21-30. PubMed ID: 19192934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIP-141, a multiple ion channel blocker, terminates aconitine-induced atrial fibrillation and prevents the rapid pacing-induced atrial effective refractory period shortening in dogs.
    Hashimoto N; Yamashita T; Fujikura N; Tsuruzoe N
    Europace; 2007 Apr; 9(4):246-51. PubMed ID: 17350982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the cardioselective, sarcolemmal K(ATP) channel blocker HMR 1098 on atrial electrical remodeling during pacing-induced atrial fibrillation in dogs.
    Vereckei A; Gögelein H; Wirth KJ; Zipes DP
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):23-30. PubMed ID: 15115900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical remodeling in atrial fibrillation. Time course and mechanisms.
    Goette A; Honeycutt C; Langberg JJ
    Circulation; 1996 Dec; 94(11):2968-74. PubMed ID: 8941128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte Ca2+ overload in atrial tachycardia: is blockade of L-type Ca2+ channels a promising approach to prevent electrical remodeling and arrhythmogenesis?
    Dobrev D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):227-30. PubMed ID: 17999053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs.
    Bénardeau A; Fareh S; Nattel S
    Cardiovasc Res; 2001 Apr; 50(1):85-96. PubMed ID: 11282081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
    Tanaka H; Shigenobu K
    Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil reduces tachycardia-induced electrical remodeling of the atria.
    Tieleman RG; De Langen C; Van Gelder IC; de Kam PJ; Grandjean J; Bel KJ; Wijffels MC; Allessie MA; Crijns HJ
    Circulation; 1997 Apr; 95(7):1945-53. PubMed ID: 9107184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral verapamil attenuates the progression of pacing-induced electrical and mechanical remodeling of the atrium.
    Kinebuchi O; Mitamura H; Shiroshita-Takeshita A; Kurita Y; Ieda M; Ohashi N; Fukuda Y; Sato T; Miyoshi S; Hara M; Takatsuki S; Nagumo M; Ogawa S
    Circ J; 2004 May; 68(5):494-500. PubMed ID: 15118295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
    Furukawa T; Miura R; Honda M; Kamiya N; Mori Y; Takeshita S; Isshiki T; Nukada T
    Br J Pharmacol; 2004 Dec; 143(8):1050-7. PubMed ID: 15545287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
    Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
    Perez-Reyes E; Van Deusen AL; Vitko I
    J Pharmacol Exp Ther; 2009 Feb; 328(2):621-7. PubMed ID: 18974361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The atrial electrical remodeling in atrial fibrillation].
    Niwano S
    Nihon Rinsho; 2002 Jul; 60(7):1308-16. PubMed ID: 12136608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.